{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:44:56Z","timestamp":1775061896140,"version":"3.50.1"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,4,15]]},"DOI":"10.2169\/internalmedicine.4016-24","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:10:52Z","timestamp":1726611052000},"page":"1229-1234","source":"Crossref","is-referenced-by-count":2,"title":["Acquired Amegakaryocytic Thrombocytopenia with Glycoprotein IIb\/IIIa Antibody in a Patient with Mantle Cell Lymphoma"],"prefix":"10.2169","volume":"64","author":[{"given":"Keijiro","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Tokutake","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoaki","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Sumi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Kuwana M. Acquired amegakaryocytic thrombocytopenia. Hematology 77: 66-70, 2018 (in Japanese)."},{"key":"2","unstructured":"2. Tirthani E, Said MS, De Jesus O. Amegakaryocytic Thrombocytopenia. In: StatPearls. StatPearls Publishing, Treasure Island (FL), 2023."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Son B, Park HS, Han HS, et al. A case of acquired amegakaryocytic thrombocytopenia with anti-c-mpl autoantibody: comparison with idiopathic thrombocytopenic purpura. Acta Haematol 142: 239-243, 2019.","DOI":"10.1159\/000499523"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Agarwal N, Spahr JE, Werner TL, Newton DL, Rodgers GM. Acquired amegakaryocytic thrombocytopenic purpura. Am J Hematol 81: 132-135, 2006.","DOI":"10.1002\/ajh.20510"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ikeda N, Hisano Y, Kamao T, Uno M, Mizushima T. Acquired amegakaryocytic thrombocytopenia associated with autoimmune hemolytic anemia. Cureus 14: e27315, 2022.","DOI":"10.7759\/cureus.27315"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kuwana M, Kaburaki J, Okazaki Y, Miyazaki H, Ikeda Y. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology 45: 851-854, 2006.","DOI":"10.1093\/rheumatology\/kel010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Levy I, Laor R, Jiries N, Bejar J, Polliack A, Tadmor T. Amegakaryocytic thrombocytopenia and subsequent aplastic anemia associated with apparent Epstein-Barr virus infection. Acta Haemato 139: 7-11, 2018.","DOI":"10.1159\/000484595"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kuwana M, Okazaki Y, Kajihara M, et al. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia. Arthritis Rheum 46: 2148-2159, 2002.","DOI":"10.1002\/art.10420"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kuter DJ, Gernsheimer TB. Thrombopoietin and platelet production in chronic immune thrombocytopenia. Hematol Oncol Clin North Am 23: 1193-1211, 2009.","DOI":"10.1016\/j.hoc.2009.09.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kuwana M. Autoantibodies to platelets: roles in thrombocytopenia. Inflamm Regen 29: 40-46, 2009.","DOI":"10.2492\/inflammregen.29.40"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cohn CS. Platelet transfusion refractoriness: how do I diagnose and manage? Hematology Am Soc Hematol Educ Program 2020: 527-532, 2020.","DOI":"10.1182\/hematology.2020000137"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ichimata S, Kobayashi M, Honda K, Shibata S, Matsumoto A, Kanno H. Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection. World J Gastroenterol 23: 6540-6545, 2017.","DOI":"10.3748\/wjg.v23.i35.6540"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Her MY, Kim TH, Chang HK, Lee WS, Yoo DH. Successful treatment of acquired amegakaryocytic thrombocytopenia with cyclosporine in adult onset Still&apos;s disease. Rheumatol Int 27: 295-298, 2007.","DOI":"10.1007\/s00296-006-0202-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ichikawa T, Shimojima Y, Otuki T, Ueno K, Kishida D, Sekijima Y. Acquired amegakaryocytic thrombocytopenia in adult-onset Still&apos;s disease: successful combination therapy with tocilizumab and cyclosporine. Intern Med 58: 3473-3478, 2019.","DOI":"10.2169\/internalmedicine.2929-19"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yamanouchi J. Immune thrombocytopenia. Nihon Kessen Shiketsu Gakkaishi (Jpn J Thromb Hemost) 29: 281-287, 2018 (in Japanese).","DOI":"10.2491\/jjsth.29.281"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood 113: 6511-6521, 2009.","DOI":"10.1182\/blood-2009-01-129155"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Hauswirth AW, Skrabs C, Schutzinger C, et al. Autoimmune thrombocytopenia in non-Hodgkin&apos;s lymphomas. Haematologica 93: 447-450, 2008.","DOI":"10.3324\/haematol.11934"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kurihara Y, Taoka K, Takagi E, Toyama K, Nakazaki K, Kurokawa M. Treatment of secondary immune thrombocytopenia with non-Hodgkin lymphoma: a case report and literature review. Intern Med 60: 1583-1588, 2021.","DOI":"10.2169\/internalmedicine.5611-20"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Meraj F, Hanif HM, Khan MR, Mansoor N. Transient acquired amegakaryocytic thrombocytopenia associated with pediatric Hodgkin lymphoma: a case report. Pediatr Hematol Oncol 6: 203-206, 2021.","DOI":"10.1016\/j.phoj.2021.09.001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lugassy G. Non-Hodgkin&apos;s lymphoma presenting with amegakaryocytic thrombocytopenic purpura. Ann Hematol 73: 41-42, 1996.","DOI":"10.1007\/s002770050199"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lewandowski K, Kowalik MM, Pawlaczyk R, Rogowski J, Hellmann A. Microscopic examination of bone marrow aspirate in healthy adults - comparison of two techniques of slide preparation. Int J Lab Hematol 34: 254-261, 2012.","DOI":"10.1111\/j.1751-553X.2011.01387.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/8\/64_4016-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T03:30:16Z","timestamp":1745033416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/8\/64_4016-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4016-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"article-number":"4016-24"}}